181 related articles for article (PubMed ID: 38397199)
21. ZNF37A promotes tumor metastasis through transcriptional control of THSD4/TGF-β axis in colorectal cancer.
Liu J; Huang Z; Chen HN; Qin S; Chen Y; Jiang J; Zhang Z; Luo M; Ye Q; Xie N; Zhou ZG; Wei Y; Xie K; Huang C
Oncogene; 2021 May; 40(19):3394-3407. PubMed ID: 33875786
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated fibroblasts-derived exosomal miR-17-5p promotes colorectal cancer aggressive phenotype by initiating a RUNX3/MYC/TGF-β1 positive feedback loop.
Zhang Y; Wang S; Lai Q; Fang Y; Wu C; Liu Y; Li Q; Wang X; Gu C; Chen J; Cai J; Li A; Liu S
Cancer Lett; 2020 Oct; 491():22-35. PubMed ID: 32730779
[TBL] [Abstract][Full Text] [Related]
23. PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.
Lai SW; Cheng YC; Kiu KT; Yen MH; Chen YW; Yadav VK; Yeh CT; Kuo KT; Chang TC
Aging (Albany NY); 2024 Jan; 16(2):1620-1639. PubMed ID: 38244581
[TBL] [Abstract][Full Text] [Related]
24. Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer.
Huang T; Lu C; Zhang Y; Lin BY; Zhang ZJ; Zhu D; Wang L; Lu Y
Ann Med; 2023; 55(2):2250987. PubMed ID: 38375814
[TBL] [Abstract][Full Text] [Related]
25. YAP, a novel target regulates F-actin rearrangement-associated CAFs transformation and promotes colorectal cancer cell progression.
Naktubtim C; Payuhakrit W; Uttarawichien T; Hassametto A; Suwannalert P
Biomed Pharmacother; 2022 Nov; 155():113757. PubMed ID: 36271545
[TBL] [Abstract][Full Text] [Related]
26. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway.
Lu C; Zhang C
Clin Transl Oncol; 2023 Jan; 25(1):160-172. PubMed ID: 36129606
[TBL] [Abstract][Full Text] [Related]
27. Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1
Hu S; Qin J; Gao R; Xiao Q; Liu X; Pan Y; Wang S
Mol Carcinog; 2023 Dec; 62(12):1787-1802. PubMed ID: 37539967
[TBL] [Abstract][Full Text] [Related]
28. Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives.
Fang Z; Meng Q; Xu J; Wang W; Zhang B; Liu J; Liang C; Hua J; Zhao Y; Yu X; Shi S
Cancer Commun (Lond); 2023 Jan; 43(1):3-41. PubMed ID: 36424360
[TBL] [Abstract][Full Text] [Related]
29. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway.
Yang W; Zhang S; Li T; Zhou Z; Pan J
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 55(2):262-273. PubMed ID: 36148955
[TBL] [Abstract][Full Text] [Related]
30. Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.
Omland SH; Wettergren EE; Mollerup S; Asplund M; Mourier T; Hansen AJ; Gniadecki R
BMC Cancer; 2017 Oct; 17(1):675. PubMed ID: 28987144
[TBL] [Abstract][Full Text] [Related]
31. miRNAs derived from cancer-associated fibroblasts in colorectal cancer.
Savardashtaki A; Shabaninejad Z; Movahedpour A; Sahebnasagh R; Mirzaei H; Hamblin MR
Epigenomics; 2019 Nov; 11(14):1627-1645. PubMed ID: 31702390
[TBL] [Abstract][Full Text] [Related]
32. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.
Wu F; Yang J; Liu J; Wang Y; Mu J; Zeng Q; Deng S; Zhou H
Signal Transduct Target Ther; 2021 Jun; 6(1):218. PubMed ID: 34108441
[TBL] [Abstract][Full Text] [Related]
33. Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin.
Ries A; Flehberger D; Slany A; Pirker C; Mader JC; Mohr T; Schelch K; Sinn K; Mosleh B; Hoda MA; Dome B; Dolznig H; Krupitza G; Müllauer L; Gerner C; Berger W; Grusch M
J Exp Clin Cancer Res; 2023 Jan; 42(1):27. PubMed ID: 36683050
[TBL] [Abstract][Full Text] [Related]
34. Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages.
Stadler M; Pudelko K; Biermeier A; Walterskirchen N; Gaigneaux A; Weindorfer C; Harrer N; Klett H; Hengstschläger M; Schüler J; Sommergruber W; Oehler R; Bergmann M; Letellier E; Dolznig H
Cancer Lett; 2021 Nov; 520():184-200. PubMed ID: 34256095
[TBL] [Abstract][Full Text] [Related]
35. Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses.
Wang Y; Chen Z; Zhao G; Li Q
Mediators Inflamm; 2023; 2023():3781091. PubMed ID: 37144239
[TBL] [Abstract][Full Text] [Related]
36. Cancer associated fibroblasts-derived exosomes contribute to radioresistance through promoting colorectal cancer stem cells phenotype.
Liu L; Zhang Z; Zhou L; Hu L; Yin C; Qing D; Huang S; Cai X; Chen Y
Exp Cell Res; 2020 Jun; 391(2):111956. PubMed ID: 32169425
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer.
Pan H; Pan J; Wu J
Front Immunol; 2022; 13():934221. PubMed ID: 35967425
[TBL] [Abstract][Full Text] [Related]
38. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
39. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation.
Yao L; Hou J; Wu X; Lu Y; Jin Z; Yu Z; Yu B; Li J; Yang Z; Li C; Yan M; Zhu Z; Liu B; Yan C; Su L
Redox Biol; 2023 Nov; 67():102923. PubMed ID: 37832398
[TBL] [Abstract][Full Text] [Related]
40. FAP
Sun L; Ke M; Wang X; Yin M; Wei J; Xu L; Tian X; Wang F; Zhang H; Fu S; Zhang C
Mol Carcinog; 2022 Oct; 61(10):910-923. PubMed ID: 35801406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
